Want to see TSE:CRDL full AI Analyst Report?

Cardiol Therapeutics (CRDL) Revenue

231 Followers

Cardiol Therapeutics Revenue

Cardiol Therapeutics had a revenue of 0.00 in the quarter ending Jun 30, 2026, with ―. This bring the company's revenue in the last twelve months to 0.00, Decreased ―. In the fiscal year ending Mar 31, 2026, Cardiol Therapeutics had annual revenue of 0.00 with ― growth.

Revenue (ttm)

0.00

Revenue Growth

―

P/S Ratio

―

Revenue/Employee

C$0

Employees

Market Cap

C$290.79M

Revenue Chart

Revenue History

Fiscal End Date	Revenue	Change	Growth
Mar 31, 2026	―	―	―
Mar 31, 2025	―	―	―
Mar 31, 2024	―	―	―
Dec 31, 2022	―	-78.76K	-100.00%
Dec 31, 2021	78.76K	―	+∞%
Mar 31, 2021	―	―	―
Dec 31, 2019	―	―	―
Dec 31, 2018	―	―	―
Dec 31, 2017	―	―	―